Table 2 Univariate and multivariate analyses of prognostic factors of PFS
From: Re-exploration of prognosis in type B thymomas: establishment of a predictive nomogram model
Variables | Univariate analyses | Multivariate analyses | ||
|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Age | 0.97 (0.94–1.00) | 0.036 | 0.99 (0.95–1.03) | 0.465 |
Surgery approach | 5.58 (2.04–15.30) | 0.001 | 1.05 (0.29–3.75) | 0.943 |
Chemotherapy | 4.24 (2.00–8.98) | < 0.001 | 0.70 (0.17–2.88) | 0.624 |
Smoking | 1.61 (0.75–3.47) | 0.221 | ||
Masaoka stage | 33.26 (7.91–139.89) | < 0.001 | 9.75 (1.97–48.22) | 0.005 |
Myasthenia gravis | 0.69 (0.33–1.47) | 0.338 | ||
Pathologic type | 1.34 (0.94–1.90) | 0.106 | ||
R0 resection status | 23.29 (10.69–50.76) | < 0.001 | 9.47 (3.16–28.44) | < 0.001 |
Radiotherapy | 4.35 (1.86–10.21) | 0.001 | 4.06 (1.15–14.42) | 0.030 |
Gender | 1.26 (0.60–2.63) | 0.543 | ||
Size | 1.02 (1.01–1.03) | 0.001 | 1.01 (0.99–1.03) | 0.429 |